Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
COO · NASDAQ · Health Care Supplies
Cooper Companies (The) (COO) · oqro.io/stocks/COO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Baskets of the companies that insiders, members of Congress or funds recently reported buying, each held under a written rule.
Yes. Insiders of Cooper Companies (The) (COO) filed 5 open-market purchases in the last 90 days; the latest was filed on Sep 17, 2026.
Since 2006, Cooper Companies (The) insiders reported 75 open-market purchases and 1,244 sales on Forms 4 and 5, with purchases in 10 different years, most recently 2026.
No open-market sale by an insider of Cooper Companies (The) (COO) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 6 trades in Cooper Companies (The) (COO) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Gilbert Ray Cisneros Jr. (CA31), Sen. Alan Armstrong.
Cooper Companies (The)'s next results are expected on Dec 2, 2026, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$60.75+0.03 (+0.05%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
−15.9% (−$11.45) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $72.20 on Nov 18, 2025 to $60.75 on Nov 18, 2026 (−15.9%). Disclosed in this range: 10 insider trades, 0 pre-arranged insider sales, 6 Congress trades, and 47 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Supplies company based in San Ramon, California.
Last 12 months
−15.9%
Market value
$11.6B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 10.1M shares sold short (5.3% of shares outstanding), +11.3% vs the previous count, 3.4 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$1.07B
+0.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$678M
This quarter $273M, a year earlier $165M
Net debt
$2.39B
Debt $2.54B, cash $155M, at Jul 31, 2026
Net income, last 12 months
$570M
Operating profit covers interest 6.1x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Sep 9, 2026.
Revenue, fiscal 2025
$4.09B
+5.1% vs the year before
Net income, fiscal 2025
$375M
As reported in the annual filing
Shares outstanding
190M
As of Sep 3, 2026
In fiscal 2025 the company spent $290M buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Congress
Traded Oct 14 · disclosed 27 days later
Since the trade +10.7% · S&P 500 −5.1% · to Nov 18
Traded Sep 14 – Sep 16, 2026 · largest single transaction ~$549K
Sep 16, 2026~$549K · 10K sh @ $54.93
DetailsOfficial recordSep 14, 2026~$539K · 10K sh @ $53.92
DetailsOfficial recordInsider buying
Their first buy on recordTraded Sep 11 · filed 4 days later
Since the trade +12.7% · S&P 500 −4.5% · to Nov 18
A Cooper director paid $379K out of pocket for Cooper shares. 2 other people at Cooper bought some too, in the same month. Shares held went up 70% with this purchase.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Cooper Companies (The) reported 75 open-market purchases and 1,244 sales since 2006; purchases in 10 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $1.88M5×5 trades | — |
| 2025 | $2.52M10×10 trades | — |
| 2024 | — | $58M16×16 trades |
| 2023 | — | $43.1M19×19 trades |
| 2022 | — | $8.2M10×10 trades |
| 2021 | — | $70.8M27×27 trades |
| 2020 | $1.06M5×5 trades | $7.69M7×7 trades |
| 2019 | — | $57.5M31×31 trades |
| 2018 | $84K2×2 trades | $38.5M35×35 trades |
| 2017 | — | $36.4M37×37 trades |
| 2016 | $50K1×1 trade | $53.4M36×36 trades |
| 2015 | — | $51.3M30×30 trades |
| 2014 | — | $41.3M25×25 trades |
| 2013 | — | $57.3M35×35 trades |
| 2012 | — | $70.8M72×72 trades |
| 2011 | — | $48.7M45×45 trades |
| 2010 | $20K2×2 trades | $15.4M42×42 trades |
| 2009 | $121K8×8 trades | $2.27M21×21 trades |
| 2008 | $1.11M22×22 trades | $4.17M5×5 trades |
| 2007 | $1.13M4×4 trades | $11.8M178×178 trades |
| 2006 | $688K16×16 trades | $42.8M573×573 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Written by software from the filings listed below · Oct 12, 2026
One more point, with the facts they come from, are in OQRO Pro.
Sign up freeTop officer leaving
“Departure of President and Chief Executive Officer On October 27, 2026, Albert G.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Against the S&P 500 over the year
Since Nov 13, 2025, COO is down 13.8% and the index fund is up 10.1%: 24 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much COO moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
On the public record for Cooper Companies (The) over the 12 months to Nov 17, 2026: 5 FDA records.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
1 approval or clearance and 4 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Last results
Sep 9, 2026
More than 30 days ago
Next results, expected
Dec 2, 2026
after the market closes; the date can move until the company confirms it
Purchases after results
83%
19 of 23 insider purchases since 2013 came within 30 days after a results announcement
From Cooper Companies (The)'s own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Cooper Companies (The)'s policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Short sale volume: 30.0% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 40.4%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 72K shares (about $4.29M) were not delivered on time for settlement on Oct 29, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
0 certified in FY2026 Q3, vs 1 a year earlier.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.